Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion type Assertion NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_head.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion wasGeneratedBy ECO_0000203 NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_provenance.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion wasDerivedFrom befree-20150227 NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_provenance.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion SIO_000772 23911702 NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_provenance.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion evidence source_evidence_literature NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_provenance.
- NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_assertion description "[Compared to CD45-low patients, CD45-high patients had a lower event-free survival rate (B-cell-precursor acute lymphoblastic leukemia: 72 ± 3% versus 86 ± 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 60 ± 8% versus 78 ± 4%, P=0.02), which was mainly attributable to a higher cumulative relapse incidence (B-cell-precursor acute lymphoblastic leukemia: 22 ± 3% versus 11 ± 1%, P<0.0001; T-cell acute lymphoblastic leukemia: 31 ± 8% versus 11 ± 3%, P=0.003) and kept its significance in multivariate analysis considering sex, age, initial white blood cell count, and minimal residual disease in B-cell-precursor- and T-cell acute lymphoblastic leukemia, and additionally presence of ETV6/RUNX1, MLL/AF4 and BCR/ABL1 rearrangements in B-cell-precursor acute lymphoblastic leukemia (P=0.002 and P=0.025, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661112.RA0yJs6sj6dfMOXpcvm3nR_gKSea7zw5OOeJIkn5O1KLA130_provenance.